• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳曲酮:临床视角

Naltrexone: a clinical perspective.

作者信息

Greenstein R A, Arndt I C, McLellan A T, O'Brien C P, Evans B

出版信息

J Clin Psychiatry. 1984 Sep;45(9 Pt 2):25-8.

PMID:6469933
Abstract

The narcotic antagonist naltrexone was studied in over 300 opiate addicts. Patient selection was a major factor in determining retention and treatment outcome. Treatment time ranged from 1 week to over a year (mean = 2 months). A quarter of the study patients had multiple treatment episodes. Stabilized patients had few side effects, except for occasional nausea and abdominal cramps. Almost half the subjects tested naltrexone by using opiates at least once; all reported satisfactory narcotic blockade. Very few subjects switched to nonopiates to get high, although several did increase their alcohol consumption during the first weeks of therapy. One-third of subjects contacted in a follow-up study were opiate-free 6 months after stopping naltrexone, indicating a successful short-term treatment modality.

摘要

对300多名阿片类药物成瘾者进行了麻醉拮抗剂纳曲酮的研究。患者选择是决定留用率和治疗结果的主要因素。治疗时间从1周到1年多不等(平均为2个月)。四分之一的研究患者有多次治疗经历。病情稳定的患者除偶尔出现恶心和腹部绞痛外,几乎没有副作用。近一半的受试者至少使用过一次阿片类药物来检测纳曲酮;所有人都报告麻醉阻滞效果令人满意。很少有受试者改用非阿片类药物来寻求快感,不过有几名受试者在治疗的头几周确实增加了饮酒量。在一项随访研究中,三分之一接受联系的受试者在停用纳曲酮6个月后未使用阿片类药物,这表明这是一种成功的短期治疗方式。

相似文献

1
Naltrexone: a clinical perspective.纳曲酮:临床视角
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):25-8.
2
Clinical experience with naltrexone in suburban opioid addicts.纳曲酮在郊区阿片类药物成瘾者中的临床经验。
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):42-5.
3
Five-year follow-up of opiate addicts with naltrexone and behavior therapy.纳曲酮与行为疗法治疗阿片类成瘾者的五年随访
NIDA Res Monogr. 1984 Mar;49:289-95.
4
Naltrexone induction: psychologic and pharmacologic strategies.纳曲酮诱导:心理和药理学策略。
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):29-38.
5
Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.纳曲酮治疗阿片类药物依赖个体的临床评估。美国国家研究委员会麻醉拮抗剂临床评估委员会报告。
Arch Gen Psychiatry. 1978 Mar;35(3):335-40.
6
Short-term effects of naltrexone in 155 heroin ex-addicts.纳曲酮对155名戒除海洛因成瘾者的短期影响。
Biol Psychiatry. 1976 Dec;11(6):679-85.
7
The sequential use of clonidine and naltrexone in the treatment of opiate addicts.可乐定与纳曲酮序贯用于阿片类成瘾者的治疗。
Adv Alcohol Subst Abuse. 1984 Spring;3(3):19-39. doi: 10.1300/J251v03n03_03.
8
Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare.盐酸可乐定用于美沙酮治疗脱毒——纳曲酮后续护理的价值。
Adv Alcohol Subst Abuse. 1984 Spring;3(3):41-9. doi: 10.1300/J251v03n03_04.
9
Naltrexone treatment in a jail work-release program.在监狱工作释放计划中使用纳曲酮治疗。
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):49-52.
10
Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran.伊朗的阿片类药物超快戒毒及随后九个月的纳曲酮维持治疗。
Pharmacopsychiatry. 2010 Jun;43(4):130-7. doi: 10.1055/s-0029-1242820. Epub 2010 Jan 25.

引用本文的文献

1
Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.开发阿片类药物使用障碍的临床决策支持:NIDA 临床试验网络工作组报告。
Addict Sci Clin Pract. 2020 Jan 16;15(1):4. doi: 10.1186/s13722-020-0180-2.
2
Naltrexone: A History and Future Directions.纳曲酮:历史与未来发展方向。
Cerebrum. 2018 Sep 1;2018. eCollection 2018 Sep-Oct.
3
Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.阿片类物质依赖者维持治疗的现有和潜在药物治疗选择。
Drugs. 2012 Jan 22;72(2):217-28. doi: 10.2165/11597520-000000000-00000.
4
Oral naltrexone maintenance treatment for opioid dependence.口服纳曲酮维持治疗阿片类物质依赖。
Cochrane Database Syst Rev. 2011 Apr 13;2011(4):CD001333. doi: 10.1002/14651858.CD001333.pub4.
5
A randomized trial of oral naltrexone for treating opioid-dependent offenders.口服纳曲酮治疗阿片类药物依赖罪犯的随机试验。
Am J Addict. 2010 Sep-Oct;19(5):422-32. doi: 10.1111/j.1521-0391.2010.00070.x.
6
The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.美沙酮、丁丙诺啡和纳曲酮对母婴的影响:人类和动物数据综述。
Curr Neuropharmacol. 2008 Jun;6(2):125-50. doi: 10.2174/157015908784533842.
7
Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program.在一项纳曲酮植入项目的临床综述中,阿片类药物戒断成功的心理社会因素及治疗相关因素
Subst Abuse Treat Prev Policy. 2007 Nov 23;2:35. doi: 10.1186/1747-597X-2-35.
8
Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics.胆汁淤积与内源性阿片类物质:肝脏疾病与外源性阿片类药物的药代动力学
Clin Pharmacokinet. 2007;46(10):825-50. doi: 10.2165/00003088-200746100-00002.
9
Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin.长效纳曲酮:对海洛因强化、主观及生理效应的拮抗作用
Psychopharmacology (Berl). 2006 Nov;189(1):37-46. doi: 10.1007/s00213-006-0509-x. Epub 2006 Sep 14.
10
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans.长效纳曲酮:对海洛因在人体作用的持久拮抗作用。
Psychopharmacology (Berl). 2002 Feb;159(4):351-60. doi: 10.1007/s002130100909. Epub 2001 Nov 1.